original ) (raw )Effectiveness and Safety of New Oxycodone/Acetaminophen Formulations With Reduced Acetaminophen for the Treatment of Low Back Pain
John Domingos
Pain Medicine, 2003
View PDFchevron_right
A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain
Todd Berner
P & T : a peer-reviewed journal for formulary management, 2011
View PDFchevron_right
Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain
Joseph Pergolizzi
Pain Medicine, 2017
View PDFchevron_right
Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain
Charles Laudadio
Journal of pain research, 2015
View PDFchevron_right
Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials
Björn Boße
BMC Clinical Pharmacology, 2010
View PDFchevron_right
Long‐term efficacy and safety of combined prolonged‐release oxycodone and naloxone in the management of non‐cancer chronic pain
Michael Hopp
… journal of clinical …, 2010
View PDFchevron_right
Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use
Errol Gould
Clinical Therapeutics, 2009
View PDFchevron_right
A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain
Srinivas Nalamachu
Journal of Pain Research, 2014
View PDFchevron_right
Oxytrex Minimizes Physical Dependence While Providing Effective Analgesia: A Randomized Controlled Trial in Low Back Pain
Nadav Friedmann , Lindsay Burns
The Journal of Pain, 2006
View PDFchevron_right
Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain
Gernot Wolfram
Health and Quality of Life Outcomes
View PDFchevron_right
Oxycodone: a review of its use in the management of pain
Asbjørn Drewes
Current Medical Research and Opinion, 2008
View PDFchevron_right
Oxycodone extended release capsules for the treatment of chronic pain
Sebastiano Mercadante
Expert Review of Neurotherapeutics, 2017
View PDFchevron_right
Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a …
Björn Boße
BMC clinical …, 2010
View PDFchevron_right
Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain
Joseph Pergolizzi
Postgraduate medicine, 2015
View PDFchevron_right
Maximizing value in opioid utilization: Is oxycodone immediate release a good option for pain management?
Joseph Pergolizzi
Aǧrı : Ağrı (Algoloji) Derneği'nin Yayın organıdır = The journal of the Turkish Society of Algology, 2015
View PDFchevron_right
Adherence and long-term effect of oxycodone/paracetamol in chronic noncancer pain: a retrospective study
Antonio Gatti
Advances in Therapy, 2011
View PDFchevron_right
Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study
Harry Ahdieh , Martin Hale
The Journal of Pain, 2007
View PDFchevron_right
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain
Björn Boße
Palliative Medicine, 2012
View PDFchevron_right
Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
Giovanni Ricevuti
Clinical Interventions in Aging, 2014
View PDFchevron_right
Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, …
Martin Hale
The Journal of Pain, 2007
View PDFchevron_right
Pain treatment with high-dose, controlled-release oxycodone: an Italian perspective
Fabio Ferrarese
Therapeutics and Clinical Risk Management
View PDFchevron_right
Oxycodone/naloxone vs oxycodone vs morphine in chronic low back pain
Dove Medical Press
2015
View PDFchevron_right
Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study
Denis Dupoiron
Drug Design, Development and Therapy, 2016
View PDFchevron_right
Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain
Christian Ruckes
International Journal of Clinical Practice, 2008
View PDFchevron_right
The Appropriateness of Long-term Opioids to Treat Chronic Back Pain
Michael Saulino
PM&R, 2012
View PDFchevron_right
Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations
Dennis Paul
Therapeutics and clinical risk management, 2015
View PDFchevron_right
Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature
Joseph Pergolizzi
Journal of Pain Research, 2012
View PDFchevron_right
The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain
Joseph Pergolizzi
Advances in therapy, 2015
View PDFchevron_right
Pain Relief and Tolerability Balance of Immediate Release Tapentadol or Oxycodone Treatment for Patients with Moderate to Severe Osteoarthritis or Low Back Pain
Shane Kavanagh
Pain Medicine, 2012
View PDFchevron_right
Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase
Zoltan Harsanyi
Clinical Therapeutics, 2010
View PDFchevron_right